Recurrent SARS-CoV-2 Omicron broadly neutralizing humanized antibodies in different single human V <sub>H</sub> 1-2-rearranging mouse models

During V(D)J recombination, antibody diversity is enhanced by nontemplated junctional modifications that generate immensely diverse heavy chain (HC) and light chain (LC) complementarity-determining 3 antigen-contact regions (CDR3s). We previously developed a mouse model that generates diverse antibody repertoires by rearranging a single human V<sub>H</sub>1-2 and Vκ1-33, associated with highly diverse CDR3s generated by V(D)J recombination with mouse Ds and/or Js. Immunization of this model with SARS-CoV-2 D614G spike elicited an antibody that potently neutralized SARS-CoV-2 variants through Omicron BA.2.754. Here, we report a related mouse model in which a single V<sub>H</sub>1-2 rearranges to human D3-3 and J<sub>H</sub>6, generating diverse HC-CDR3s much longer on average than those of our prior model. Omicron BA.4/.5 spike-ferritin nanoparticle-immunization of the new model elicited four highly related humanized antibodies that potently neutralize downstream Omicron subvariants. All four antibodies had 12 AA HC-CDR3s with two aromatic amino acids that engage an epitope comprising a hydrophobic patch opened-up by early Omicron lineage mutations and conserved in subsequent variants. Immunization of our prior, shorter CDR3-based model, elicited slightly less potent neutralizing antibodies that bound the same Omicron epitope, and were similar in all other aspects to those from the long, fully human CDR3 model. One tested antibody from each set reduced lung viral titers in a mouse-adapted BQ1.1 challenge. The antibodies we describe are related in their epitope recognition to recently described antibodies from Omicron-infected humans. These studies validate the utility of single human V<sub>H</sub>- and Vκ-rearranging mice for discovering humanized antibodies that neutralize emerging pathogens.

Authors

Institutions

Publication Details

Journal
Proceedings of the National Academy of Sciences
Published
2026-03-23
DOI
https://doi.org/10.1073/pnas.2537053123
Primary Topic
SARS-CoV-2 and COVID-19 Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Recurrent SARS-CoV-2 Omicron broadly neutralizing humanized antibodies in different single human V H 1-2-rearranging mouse models

Yunlong Cao, Kenneth Cronin, Jaclyn S. Higgins, Esther M. Lee et al.
Proceedings of the National Academy of Sciences
SARS-CoV-2 and COVID-19 Research
article

Recurrent SARS-CoV-2 Omicron broadly neutralizing humanized antibodies in different single human V H 1-2-rearranging mouse models

Yunlong Cao, Kenneth Cronin, Jaclyn S. Higgins, Esther M. Lee, Frederick W. Alt, Fanchong Jian, Melissa D. Mattocks, Craig Anthony Williams, Adam Yongxin Ye, Bart Haynes, Sai Luo, Himanshu Batra, R. J. Edwards, Ming Tian, Geeyoun Jung, Ralph S. Baric, Katayoun Mansouri, Michael L. Mallory, Bing Chen, Md Golam Kibria, G. M. Jonaid, Qingchen J. Zhou, David C. Montefiori, Kevin O. Saunders, Amanda Eaton, Robert Parks, Jun Zhang, S. Munir Alam
article en

Abstract

During V(D)J recombination, antibody diversity is enhanced by nontemplated junctional modifications that generate immensely diverse heavy chain (HC) and light chain (LC) complementarity-determining 3 antigen-contact regions (CDR3s). We previously developed a mouse model that generates diverse antibody repertoires by rearranging a single human V<sub>H</sub>1-2 and Vκ1-33, associated with highly diverse CDR3s generated by V(D)J recombination with mouse Ds and/or Js. Immunization of this model with SARS-CoV-2 D614G spike elicited an antibody that potently neutralized SARS-CoV-2 variants through Omicron BA.2.754. Here, we report a related mouse model in which a single V<sub>H</sub>1-2 rearranges to human D3-3 and J<sub>H</sub>6, generating diverse HC-CDR3s much longer on average than those of our prior model. Omicron BA.4/.5 spike-ferritin nanoparticle-immunization of the new model elicited four highly related humanized antibodies that potently neutralize downstream Omicron subvariants. All four antibodies had 12 AA HC-CDR3s with two aromatic amino acids that engage an epitope comprising a hydrophobic patch opened-up by early Omicron lineage mutations and conserved in subsequent variants. Immunization of our prior, shorter CDR3-based model, elicited slightly less potent neutralizing antibodies that bound the same Omicron epitope, and were similar in all other aspects to those from the long, fully human CDR3 model. One tested antibody from each set reduced lung viral titers in a mouse-adapted BQ1.1 challenge. The antibodies we describe are related in their epitope recognition to recently described antibodies from Omicron-infected humans. These studies validate the utility of single human V<sub>H</sub>- and Vκ-rearranging mice for discovering humanized antibodies that neutralize emerging pathogens.

Proceedings of the National Academy of SciencesVol. 123(13)
University of North Carolina at Chapel Hill (US), Boston Children's Hospital (US), International Vaccine Institute (KR), Howard Hughes Medical Institute (US), Harvard University (US), Pioneer (United States) (US), Duke University (US), Peking University (CN)
Openalex Percentile: Top 13%
SARS-CoV-2 and COVID-19 Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.